Rare diseases
Investigational molecules
Locations
474 conditions with trials, the busiest first
1 133 trials across Europe, recruiting first
Study on Mirikizumab for Children and Teens with Moderate to Severe Ulcerative Colitis
BelgiumStudy Comparing Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil to Standard Treatment for Patients with Advanced Anal Cancer
FranceStudy on Calcium Chloride Hexahydrate, Irreversible Electroporation, and Pembrolizumab for Patients with Metastatic Colorectal Cancer
DenmarkStudy of Oxaliplatin and Nivolumab for Patients with Metastatic Colorectal Cancer
NorwayStudy on the Safety and Effectiveness of Magrolimab with Bevacizumab and Drug Combination for Patients with Advanced Metastatic Colorectal Cancer
BelgiumStudy of CGT9486 and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors
CzechiaStudy on Gallium (68Ga) Tezatabep Matraxetan PET for Evaluating HER2 Status in Patients with Gastro-Esophageal and HER2-Low Breast Cancer
SwedenStudy on the Safety and Effects of MBF-118 for Crohn's Disease Patients with Stenosis
SpainStudy on Octreotide for Nutritional Recovery After Surgery in Esophageal or Gastric Cancer Patients
SwedenStudy of DKN-01 with Drug Combination for Patients with Advanced Colorectal Cancer
GermanyStudy on Aspirin for Preventing Recurrence and Improving Survival in Patients with Stage II and III Colon Cancer
The NetherlandsStudy on Botensilimab Alone and with Balstilimab or Drug Combination for Patients with Refractory Metastatic Colorectal Cancer
BelgiumThe therapies tested most often in Gastrointestinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
